SCHEMBL2884810

SCHEMBL2884810

COc1ccc(/C=C(/C(=O)O)C(C)(C)C)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.50
ATM Q13315 1/20 0.50
CYP1A2 P05177 2/20 0.49
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 2/20 0.49
MAPT P10636 2/20 0.49
HPGD P15428 2/20 0.49
AKR1C3 P42330 1/20 0.48
F3 P13726 1/20 0.47
CYP3A4 P08684 2/20 0.46
NFKB1 P19838 2/20 0.46
TSHR P16473 1/20 0.46
APEX1 P27695 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CYP2A6 P11509 1/20 0.46
GSK3B P49841 2/20 0.45
BACE1 P56817 1/20 0.45
PPARA Q07869 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2884806 1.00 THRB (0.50) THRBATMCYP1A2ALDH1A1KDM4E
SCHEMBL2687754 0.86 KDM4E (0.47) THRBATMCYP1A2ALDH1A1KDM4E
SCHEMBL2687755 0.86 KDM4E (0.47) THRBATMCYP1A2ALDH1A1KDM4E
SCHEMBL8170616 0.80 ALDH1A1 (0.51) ALDH1A1KDM4EMAPTHPGDF3
SCHEMBL1580086 0.80 EGFR (0.49) ALDH1A1KDM4EAKR1C3CYP2A6KMT2A
SCHEMBL1580085 0.80 EGFR (0.49) ALDH1A1KDM4EAKR1C3CYP2A6KMT2A
SCHEMBL525211 0.80 AKR1C3 (0.55) ALDH1A1AKR1C3CYP3A4TSHRKMT2A
SCHEMBL525210 0.80 AKR1C3 (0.55) ALDH1A1AKR1C3CYP3A4TSHRKMT2A
SCHEMBL16225272 0.79 TRPA1 (0.47) CYP1A2ALDH1A1MAPTAKR1C3NPSR1
SCHEMBL16225273 0.79 TRPA1 (0.47) CYP1A2ALDH1A1MAPTAKR1C3NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100121069-A1 METHOD FOR MANUFACTURING A BETA-DIARYL ELECTRON WITHDRAWING GROUP SUBSTITUTED COMPOUND MSD K.K. (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100121069-A1 METHOD FOR MANUFACTURING A BETA-DIARYL ELECTRON WITHDRAWING GROUP SUBSTITUTED COMPOUND BMP6, GPR6, ACSL6 THRB 904/4885ATM 4173/4885CYP1A2 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.